PULSE OF THE HILL · HEALTHCARE RESEARCH PREVIEW
Healthcare advocacy, connected to the policy record.
Source-backed briefs on rehabilitation, rare disease, urgent care, pharmacy and cardiovascular advocacy—with the actual events and dated disclosures behind each case.
Selected public examples. Fixed editorial snapshot, not a live feed, customer workspace or unlocked directory. No signup required. Full records and ongoing research require paid access.
THE NAMED EVENTS · THE RIGHT POLICY RECORD
Choose a source-backed case.
Open the case closest to your work. Each fixed sample separates source facts, historical disclosures and preparation steps. Full records stay paid.
Case sources reviewed October 27, 2026. Open a brief for the primary evidence and preparation checklist.
HDA · distribution policy, DSCSA scope and pharmacy advocacyPolicy review: October 27, 2026 · NCPA: April 7–8, 2027Keep a limited regulatory exemption separate from a pharmacy advocacy date and a disclosed lobbying relationship.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Organization fact · pharmaceutical distribution
HDA identifies traceability, distributor licensing and drug shortages among its policy priorities. That is the distribution-policy context for this brief, not a claim that every pharmacy association shares HDA’s positions.
HDA: pharmaceutical-distribution policy priorities ↗Separate organizer fact · NCPA Congressional Pharmacy Fly-In
NCPA announces April 7–8, 2027 for its next congressional fly-in. This is a pharmacy-sector planning reference, not an HDA event or a confirmed joint agenda.
NCPA: next Congressional Pharmacy Fly-In ↗2 · THE DATED POLICY RECORD
HDA’s own disclosure · Q3 2026 in-house LD-2
The report names drug shortages, the strategic national stockpile and pharmaceutical supply-chain policy. It adds HDA-specific historical context, not a final 2027 pharmacy agenda or proof that the FDA exemption applies to every distributor.
HDA: Q3 2026 in-house LD-2 report ↗Agency record · FDA letter issued August 6, 2026
FDA extends specified DSCSA exemptions for eligible small business dispensers, and where stated their trading partners, from November 27, 2026 through November 27, 2027. Other requirements still apply; this is not an across-the-board deadline extension for distributors.
FDA: August 6, 2026 small-dispenser exemption letter ↗Separate historical registration · BGR / NCPA · June 2026 LD-1
BGR’s NCPA registration describes healthcare legislative and regulatory advocacy. It is a pharmacy-policy research lead, not an HDA disclosure, a DSCSA-specific engagement or proof of a final 2027 event ask.
BGR / NCPA: June 2026 LD-1 registration ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- In a distribution briefing, record the FDA letter’s issue date, exemption period and limited scope separately from the wider DSCSA implementation timeline.
- Use April 7–8 as a pharmacy advocacy watch window; confirm NCPA’s current priorities before connecting a specific bill or DSCSA request to that event.
- Keep HDA policy priorities, the FDA source and the separate NCPA registration in distinct source-labeled sections so a colleague can audit the briefing without rebuilding the searches.
What this evidence does not establish
No HDA fly-in date, joint delegation, shared legislative position or participation by a disclosed firm is established. This is not a dispenser-specific compliance opinion or a conclusion that any distributor or transaction qualifies for an exemption.
Connected platform coverage
Verified 2026 Q1–Q3 disclosures are linked in Pulse. The full source-record view requires existing paid access; the public sample does not unlock it. Some printed/API person names remain unresolved, and this is not complete historical coverage.
Open HDA’s connected organization record →Foundations Health Solutions · certification funding versus facility financingLD-1 filed October 26, 2026 · AHCA/NCAL: June 7–8, 2027Build two policy tracks for the same skilled-nursing account: CMS certification funding and HUD/FHA facility financing.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Separate organizer fact · AHCA/NCAL Congressional Briefing
AHCA/NCAL lists June 7–8, 2027 in Washington, DC. This is a relevant long-term-care advocacy window to monitor, not evidence that Foundations is attending or endorses the organizer’s eventual meeting asks. Older hidden scheduling text on the page is not a 2027 appointment schedule.
AHCA/NCAL: 2027 Congressional Briefing ↗2 · THE DATED POLICY RECORD
Official registration · Thorn Run / Foundations · effective October 1, 2026
The LD-1 was signed October 26, 2026. It identifies FY2027 Labor-HHS appropriations concerning CMS survey and certification of newly constructed nursing homes, separately from HUD/FHA Section 232 policy for financing new skilled nursing facilities. This is a registration, not a quarterly activity report.
Thorn Run / Foundations Health Solutions: October 2026 LD-1 ↗Agency context · HUD Section 232
HUD describes Section 232 as mortgage insurance for healthcare-facility financing. That is a different policy channel from the CMS certification-funding issue in the registration; it is not a Medicare reimbursement-rate measure or a grant award.
HUD: Section 232 healthcare-facility mortgage insurance ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- Create a CMS/Labor-HHS funding lane and a separate HUD/FHA financing lane, each with its own source and next research question.
- For the funding lane, verify the current appropriations vehicle and relevant certification provisions; do not invent a bill number from a broad issue description.
- For the financing lane, track current HUD program material separately and keep the June 7–8 industry advocacy window as a planning reference—not a booked client meeting.
What this evidence does not establish
No specific bill, appropriation outcome, mortgage approval, client attendance or shared AHCA/NCAL agenda is established. The registration does not prove work completed, fees paid, eligibility for financing or the status of a particular facility.
Connected platform coverage
The verified October 2026 Thorn Run LD-1 and its CMS/HUD issue descriptions are linked in Pulse. Full source records require existing paid access. One person-name discrepancy remains unresolved; this is not an LD-2 activity report or proof of AHCA/NCAL attendance.
Open Foundations’ connected organization record →AMRPA · rehabilitation and Medicare reimbursementMarch 14–16, 2027Prepare a rehabilitation-specific reimbursement brief, not a generic healthcare event list.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Organizer fact · AMRPA Congressional Fly-In
The American Medical Rehabilitation Providers Association lists its Spring Conference & Congressional Fly-In for March 14–16, 2027 in Washington, DC. The event range is not a confirmed day-by-day congressional meeting schedule.
AMRPA: 2027 Spring Conference & Congressional Fly-In ↗2 · THE DATED POLICY RECORD
Historical disclosure · Alston & Bird / AMRPA · Q1 2026 LD-2
The report identifies Medicare reimbursement as a lobbying issue for AMRPA. It provides a documented payment-policy starting point for the rehabilitation brief.
Alston & Bird / AMRPA: Q1 2026 LD-2 ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- Use March 14 as the preparation deadline for the conference window, then confirm the designated Hill-visit day.
- Refresh the Medicare reimbursement issue against AMRPA’s current policy materials before naming a bill or drafting a leave-behind.
- Keep the organizer announcement and dated disclosure beside the payment question in the account brief.
What this evidence does not establish
The Q1 2026 filing is not a confirmed 2027 agenda, attendee list or evidence that the disclosed firm will participate in the fly-in. No specific bill or reimbursement outcome is established here.
RARE Disease Week · therapy development and PDUFAMarch 2–4, 2027Separate rare-disease research funding from the drug-user-fee policy track.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Organizer fact · Rare Disease Week on Capitol Hill
RARE Advocates announces March 2–4, 2027 for Rare Disease Week. The event page establishes the advocacy window; it does not by itself establish final bill-specific meeting asks.
RARE Advocates: Rare Disease Week 2027 ↗2 · THE DATED POLICY RECORD
Historical disclosure · Faegre Drinker / EveryLife Foundation · Q2 2026 LD-2
Filed under the EveryLife Foundation for Rare Diseases name, this report describes rare-disease therapy development, the upcoming FDA Prescription Drug User Fee Act (PDUFA) reauthorization, and FY2027 policy and program requests for therapy development and research.
Faegre Drinker / EveryLife Foundation: Q2 2026 LD-2 ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- Build separate sections for FY2027 research/program funding and PDUFA-related therapy-development policy.
- Check the current reauthorization process and organizer priorities before inserting a bill number or specific request.
- Use the March 2–4 window to set a briefing deadline; verify individual congressional appointments separately.
What this evidence does not establish
A historical disclosure is not the final Rare Disease Week platform or proof of event attendance. It does not establish a client relationship with the reader, a shared delegation or a current bill endorsement.
UCA + AAFP · urgent and primary-care policyUCA: February 2–3 · AAFP: May 23–25, 2027Keep urgent-care reimbursement and family-medicine policy in distinct preparation lanes.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Organizer fact · UCA Capitol Hill Advocacy Day
The Urgent Care Association lists February 2–3, 2027 for its invitation-only Washington advocacy program and identifies better urgent-care reimbursement as its top priority.
Urgent Care Association: Capitol Hill Advocacy Day ↗Organizer fact · AAFP Family Medicine Advocacy Summit
AAFP lists May 23–25, 2027 in Washington, DC and describes meetings with congressional offices. This is a different organizer, care setting and event window from UCA.
AAFP: Family Medicine Advocacy Summit ↗2 · THE DATED POLICY RECORD
Historical disclosure · Cozen O’Connor Public Strategies / AAFP · Q1 2026 LD-2
AAFP’s disclosed issues concern primary care, healthcare funding and public health. This is an AAFP policy record, not a UCA filing and not proof of a joint reimbursement position.
Cozen O’Connor / AAFP: Q1 2026 LD-2 ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- Prepare the February urgent-care brief around UCA’s stated reimbursement priority.
- Prepare the May family-medicine brief separately, using the AAFP filing as historical context and checking current priorities.
- Keep sources and meeting asks attached to the right organization; do not carry one care setting’s request into the other’s materials.
What this evidence does not establish
No common agenda, coalition, shared delegation, individual appointment or final bill-specific ask is established. The Cozen filing does not establish representation of UCA.
NCPA + NHIA · pharmacy and Medicare home infusionNHIA: November 19, 2026 · NCPA: April 7–8, 2027Use the pharmacy registration and the home-infusion event for different research questions.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Organizer fact · NCPA Congressional Pharmacy Fly-In
NCPA’s official recap announces its next Congressional Pharmacy Fly-In for April 7–8, 2027. The prior event’s legislative wins are not a confirmed 2027 agenda.
NCPA: next Congressional Pharmacy Fly-In ↗Organizer fact · NHIA Advocacy in Action
NHIA lists November 19, 2026 congressional meetings focused on Medicare beneficiaries’ access to home infusion. Its historical 2025 bill reference is not confirmation of the final 2026 ask.
NHIA: Advocacy in Action Hill day ↗2 · THE DATED POLICY RECORD
Historical registration · BGR / NCPA · June 2026 LD-1
BGR’s registration for the National Community Pharmacists Association describes counsel and advocacy on healthcare legislation and regulation. This is a registration, not a Q2 activity report or a bill-specific pharmacy platform.
BGR / NCPA: June 2026 LD-1 registration ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- Keep the November home-infusion deadline separate from the April pharmacy fly-in.
- Use the BGR registration to establish the disclosed relationship and broad policy scope—not a specific meeting ask.
- Confirm each organizer’s current reimbursement priorities and any current bill references before preparing the final brief.
What this evidence does not establish
No joint delegation, common agenda, event attendance or shared bill position is established. A registration does not demonstrate quarterly lobbying activity or a particular legislative result.
SCAI + RARE · two March healthcare advocacy tracksRARE: March 2–4 · SCAI: March 8, 2027Brief cardiovascular access and rare-disease therapy policy separately, even in the same month.Read the brief & sources
1 · ORGANIZATION & EVENT FACTS
Organizer fact · SCAI Capitol Hill Advocacy Day
SCAI announces March 8, 2027, in conjunction with CRT 2027. Its focus includes patient access, physician practice and cardiovascular care; the page describes congressional meetings and policy briefings.
SCAI: Capitol Hill Advocacy Day 2027 ↗Organizer fact · Rare Disease Week
RARE Advocates lists March 2–4, 2027. This is a separate advocacy program earlier in March, not a joint event with SCAI.
RARE Advocates: Rare Disease Week 2027 ↗2 · THE DATED POLICY RECORD
Separate policy context · Faegre Drinker / EveryLife Foundation · Q2 2026 LD-2
The EveryLife disclosure identifies rare-disease therapy development, PDUFA reauthorization and FY2027 research/program requests. These are rare-disease policy leads, not SCAI positions or evidence of a common campaign.
Faegre Drinker / EveryLife Foundation: Q2 2026 LD-2 ↗3 · PULSE ANALYSIS · A PRACTICAL HANDOFF
What goes in the preparation brief
- Set distinct preparation deadlines for March 2–4 and March 8.
- For SCAI, verify the current cardiovascular access and physician-practice requests rather than importing its 2026 recap.
- For the rare-disease brief, separately update the PDUFA and research-funding threads from the dated disclosure.
What this evidence does not establish
No coalition, common congressional target, shared agenda or attendance by the disclosed firm is established. The EveryLife filing must not be attributed to SCAI.
Full worked example · Three days of Hill visits. Two Medicare access questions.November 17–19, 2026Read the analysis & sources
FULL WORKED EXAMPLE
Three days of Hill visits. Two Medicare access questions.
A finished reimbursement-research example: ambulance advocacy, home infusion and the distinction between a disclosed issue and an event’s actual ask.
Sources reviewed October 26, 2026 · November 17–19, 2026
THE ACCOUNT-BRIEF TAKEAWAY · PULSE ANALYSIS
Prepare separate reimbursement briefs for two different care settings.
Ground ambulance and home infusion advocates have nearby Hill activity, but the policy questions are not interchangeable. Start the ambulance brief with its documented payment issues; use NHIA’s stated Medicare-access focus for the home infusion brief. Check current bill status and each organizer’s latest materials before naming a meeting ask.
1 · THE SOURCE-BACKED RECORD
Event → organization → policy record
American Ambulance Association · Stars of Life
The agenda lists congressional visits November 17, 9 a.m.–5 p.m., and November 18, 8:30 a.m.–12:30 p.m. The broader program includes other activities; a registration or awards event is not an office appointment.
AAA: 2026 Stars of Life agenda ↗National Home Infusion Association · Advocacy in Action
NHIA lists congressional meetings for November 19, 2026, 9 a.m.–3 p.m., focused on equitable home infusion access for Medicare beneficiaries. Its separate 2025 recap names the Preserving Patient Access to Home Infusion Act; that historical reference is not confirmation of the final 2026 bill-specific ask.
NHIA: 2026 Hill day and historical advocacy recap ↗An actual disclosure supplies the policy thread
Alston & Bird’s Q1 2026 American Ambulance Association report names H.R. 2232 / S. 1643 on Medicare ground-ambulance payment. This is historical 119th-Congress disclosure context, not proof of the final Stars of Life talking points or attendance.
Alston & Bird / AAA: Q1 2026 LD-2 ↗2 · A USABLE RESEARCH HANDOFF
What to put in the account brief
- Put the November 17–18 ambulance visits and November 19 home infusion visit into separate preparation deadlines.
- Check the ambulance bill references against current legislative status; verify the final event asks with each organizer.
- Keep each care setting’s payment question, source and next research action together in the client brief.
What this evidence does not establish
No shared agenda, coalition, attendee list, office availability or booked meetings is established. The disclosure does not prove event participation. This sample does not resolve bill status or make a reimbursement/compliance determination.
Organizer facts, historical disclosures and Pulse analysis are labeled separately. Confirm current dates, bill status and participation directly before relying on them.
3 · CHECK THE WORK
Primary sources for this fixed example
- AAA: 2026 Stars of Life agenda ↗Organizer agenda · reviewed October 26, 2026
- NHIA: 2026 Hill day and historical advocacy recap ↗Organizer advocacy page · reviewed October 26, 2026
- Alston & Bird / AAA: Q1 2026 LD-2 ↗Official lobbying disclosure · reviewed October 26, 2026
Need a finished brief on your own question?
$1,000 one-time for one agreed federal research brief—not a subscription or ongoing monitoring. Scope and availability confirmed before payment.
See the deliverable and request scope confirmation →WHAT YOU WOULD BE PAYING FOR
Keep this research connected across your accounts.
These samples show selected finished cases. Federal Intelligence is the research product behind the workflow—not a purchase of these public facts or an unlimited bespoke briefing service.
Full tracked calendar
Research current federal advocacy events across the tracked calendar, beyond this selected pair.
Connected policy research
Open organization, bill and lobbying-disclosure records and follow their sources. Not every event has a verified bill or filing link.
Your research workspace
Keep private notes and preparation context together, with maintained records and verified updates as coverage develops.
$2,500 one-time for three months, or $9,000 for twelve months prepaid. One named user; additional seats quoted separately. Fixed terms, no automatic renewal.
No meeting, scope email or agreement request is required for standard access. After verified successful payment, we activate access within one business day and email a secure setup link. Your term starts at activation. Opening checkout does not charge you or unlock records.
SEE A FINISHED RESEARCH OUTPUT
Choose an example close to your work.
Fixed, source-linked examples. No signup needed to read a sample; the full calendar, connected records and maintained research stay paid.